Clin2
NCT05879913Possibly a fitRecruiting

Heart risk check using CT scan in men on prostate cancer therapy

Prostate Cancer

Part of Cancer, Heart & circulation, Kidney & urinary clinical trials.

This study looks at how a special CT heart scan (CCTA) can help manage heart disease risk in men with prostate cancer who are taking hormone therapy (ADT). It may help your care team better assess heart risk, especially if you also have other heart risk factors but no current heart symptoms.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
100 people
Ages
40 years and older
Study type
Interventional

Who can take part

  • You can sign consent and allow release of your health records for the study
  • You are age 40 or older
  • You have had prostate cancer and are currently on ADT or planning to start ADT for more than 12 months
  • You have at least one heart risk factor such as high blood pressure, high cholesterol, diabetes, or tobacco use
  • You do not have current heart/chest symptoms (like chest pain, shortness of breath from heart disease)
  • You are not getting certain chemotherapy drugs at the time you sign consent

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06163924Recruiting
Heart risk reduction in prostate cancer patients on hormone therapy

This study tests whether a team of doctors, nurses, and other specialists can help reduce the risk of heart problems in men with prostate cancer who are on hormone therapy (ADT). It focuses on providing extra support for heart health.

Hong Kong
NCT06064149Recruiting
Heart risk study for men on hormone therapy for prostate cancer

This study looks at heart health in men with prostate cancer who are taking or will take hormone therapy (ADT) for at least 6 months. It aims to learn more about cardiovascular risks and how to manage them.

Philadelphia, Pennsylvania
NCT06202820Recruiting
Heart health monitoring for men on hormone therapy

This study checks how men starting hormone therapy (ADT) for prostate cancer are doing with their heart health. It offers follow-up visits at the cancer center to track blood pressure and lab results, with the goal of catching any heart-related issues early.

Boston, Massachusetts
NCT06793774Recruiting
Using CT scans and AI to evaluate heart artery risk

This study uses a CT scan of your heart (CCTA) and advanced computer analysis to see how well it can predict heart risks compared to detailed inside-look tests (IVUS, OCT, NIRS). If you have chest pain and have had certain heart scans, this trial may help doctors understand your condition better.

Shanghai, Shanghai Municipality
NCT07220304Not yet recruiting
Heart CT scan risk assessment study

This trial uses a special computer program to look at your heart CT scan and measure inflammation and risk of heart problems. It may help doctors better understand your risk and guide your treatment.

Bay City, Michigan
NCT06949150Recruiting
Combined heart CT scan study for coronary artery disease

This study tests a new way to use CT scans to look at both the structure of your heart arteries and how well blood flows through them. It may help doctors get a more complete picture of coronary artery disease without extra procedures.

Shanghai, Shanghai Municipality

Hear when a new Prostate cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.